Stacy Lindborg, Imunon President & CEO, on Bold Biotech, IL-12 Immunotherapy & Phase 3 Trials
Synopsis: What does bold biotech leadership look like in 2025? In this episode of Biotech 2050, host Alok Tayi sits down with Stacy Lindborg, President & CEO of Imunon, to discuss bold innovation i...
14 Touko 202517min
Stephanie Sirota, CBO & Partner at RTW Investments, on Biotech Investing, Policy & Bold Bet Building
Synopsis: What happens when a former journalist becomes one of biotech’s boldest investors? Meet Stephanie Sirota, Chief Business Officer and Partner at RTW Investments, who helped grow the firm fro...
8 Touko 202524min
Steve Tregay on Leading Mission BioCapital as Managing Partner & Fueling Early-Stage Biotech
Synopsis: Building in biotech isn’t for the faint of heart—especially during a market downturn. But that’s exactly when Steve Tregay, Managing Partner at Mission BioCapital, thrives. A seasoned en...
3 Huhti 202541min
Neil F. McFarlane, President & CEO of Zevra Therapeutics, on Leading Rare Disease Innovation
Synopsis: In this episode of Biotech2050, host Rahul Chaturvedi sits down with Neil F. McFarlane, President and CEO of Zevra Therapeutics, to explore his unique leadership journey from military nurs...
26 Maalis 202535min
Raj Devraj, President & CEO - Rectify Pharma, on Drug Discovery, Biotech Breakthroughs & Growth
Synopsis: How do you build a biotech company that disrupts drug discovery and delivers real impact? In this episode of Biotech 2050, host Rahul Chaturvedi speaks with Raj Devraj, President & CEO of ...
20 Maalis 202534min
Revolutionizing CAR T with CRISPR: Rachel Haurwitz, President & CEO of Caribou Biosciences
Synopsis: Host Rahul Chaturvedi welcomes back Rachel Haurwitz, President & CEO of Caribou Biosciences, for a deep dive into the future of CRISPR-based genome editing and its transformative impact on...
11 Maalis 202526min
Liam Killingstad on How Family Offices Quietly Fuel Biotech’s Boldest Innovations
Synopsis: In this thought-provoking episode of Biotech 2050, host Alok Tayi sits down with Liam Killingstad, Member at Finiam Investments, to unpack the growing influence of family offices in biotec...
6 Maalis 202559min
Clare Terlouw, Head of LifeArc Ventures, on Bridging Biotech’s Funding Gap & Investing for Impact
Synopsis: Host Alok Tayi sits down with Clare Terlouw, Head of Ventures at LifeArc Ventures, to explore biotech investing from an LP perspective. Clare shares her unique journey—from physiotherapy t...
26 Helmi 202542min
